1. Home
  2. AIRS vs GNFT Comparison

AIRS vs GNFT Comparison

Compare AIRS & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIRS
  • GNFT
  • Stock Information
  • Founded
  • AIRS 2012
  • GNFT 1999
  • Country
  • AIRS United States
  • GNFT France
  • Employees
  • AIRS N/A
  • GNFT N/A
  • Industry
  • AIRS Medical/Nursing Services
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AIRS Health Care
  • GNFT Health Care
  • Exchange
  • AIRS Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • AIRS 166.3M
  • GNFT 186.3M
  • IPO Year
  • AIRS 2021
  • GNFT 2019
  • Fundamental
  • Price
  • AIRS $4.93
  • GNFT $3.75
  • Analyst Decision
  • AIRS Hold
  • GNFT Strong Buy
  • Analyst Count
  • AIRS 3
  • GNFT 1
  • Target Price
  • AIRS $3.75
  • GNFT $13.00
  • AVG Volume (30 Days)
  • AIRS 606.4K
  • GNFT 4.0K
  • Earning Date
  • AIRS 08-08-2025
  • GNFT 04-24-2025
  • Dividend Yield
  • AIRS N/A
  • GNFT N/A
  • EPS Growth
  • AIRS N/A
  • GNFT N/A
  • EPS
  • AIRS N/A
  • GNFT 0.03
  • Revenue
  • AIRS $172,101,000.00
  • GNFT $73,187,701.00
  • Revenue This Year
  • AIRS N/A
  • GNFT $15.98
  • Revenue Next Year
  • AIRS $4.90
  • GNFT N/A
  • P/E Ratio
  • AIRS N/A
  • GNFT $120.71
  • Revenue Growth
  • AIRS N/A
  • GNFT 105.01
  • 52 Week Low
  • AIRS $1.53
  • GNFT $2.55
  • 52 Week High
  • AIRS $9.20
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • AIRS 53.44
  • GNFT 44.52
  • Support Level
  • AIRS $4.93
  • GNFT $3.44
  • Resistance Level
  • AIRS $5.65
  • GNFT $3.81
  • Average True Range (ATR)
  • AIRS 0.38
  • GNFT 0.17
  • MACD
  • AIRS -0.06
  • GNFT -0.00
  • Stochastic Oscillator
  • AIRS 34.78
  • GNFT 56.65

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: